Benitec Biopharma Inc. – NASDAQ:BNTC
Benitec Biopharma stock price today
$12.56
+0.56
+4.67%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Benitec Biopharma stock price monthly change
+26.72%
month
Benitec Biopharma stock price quarterly change
+26.72%
quarter
Benitec Biopharma stock price yearly change
+269.23%
year
Benitec Biopharma key metrics
Market Cap | 252.13M |
Enterprise value | N/A |
P/E | -0.13 |
EV/Sales | -65.01 |
EV/EBITDA | 0.21 |
Price/Sales | 93.88 |
Price/Book | 0.64 |
PEG ratio | N/A |
EPS | -17.72 |
Revenue | N/A |
EBITDA | -17.57M |
Income | -18.46M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -30396.77% |
Oper. margin | -29658.06% |
Gross margin | 62.9% |
EBIT margin | -29658.06% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBenitec Biopharma stock price history
Benitec Biopharma stock forecast
Benitec Biopharma financial statements
Average Price Target
$20.33
Potential upside: 61.88%
Analysts Price target
Financials & Ratios estimates
| Jun 2022 | 0 | -5.06M | |
|---|---|---|---|
| Mar 2023 | 54K | -4.46M | -8259.26% |
| Jun 2023 | 7K | -4.66M | -66585.71% |
| Mar 2024 | 6K | -4.27M | -71316.67% |
| Dec 2022 | 11905000 | 2.91M | 24.45% |
|---|---|---|---|
| Mar 2023 | 8220000 | 3.50M | 42.66% |
| Jun 2023 | 4464000 | 4.26M | 95.47% |
| Mar 2024 | 14999000 | 3.49M | 23.33% |
| Jun 2022 | -4.85M | -13K | 0 |
|---|---|---|---|
| Mar 2023 | -4.02M | -462.04K | 462.04K |
| Jun 2023 | -4.09M | -1K | -264.58K |
| Mar 2024 | -6.23M | -179.42K | 154.88K |
Benitec Biopharma alternative data
| Aug 2023 | 18 |
|---|---|
| Sep 2023 | 18 |
| Oct 2023 | 18 |
| Nov 2023 | 18 |
| Dec 2023 | 17 |
| Jan 2024 | 17 |
| Feb 2024 | 17 |
| Mar 2024 | 18 |
| Apr 2024 | 18 |
| May 2024 | 16 |
| Jun 2024 | 16 |
| Jul 2024 | 16 |
Benitec Biopharma other data
37.67%
-62.33%
of BNTC is owned by hedge funds
10
-13
10.38M
-1.92M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2024 | 41436 | 0 |
| Dec 2024 | 89520 | 0 |
| Quarter | Transcript |
|---|---|
| Q3 2018 1 Jun 2018 | Q3 2018 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Dr. Jerel A. Banks M.D., Ph.D. (1975) Chief Executive Officer & Executive Chairman | $697,690 |
Ms. Megan Joan Boston BComm, CA, Dip., GAICD (1972) Executive Director | $401,700 |
-
What's the price of Benitec Biopharma stock today?
One share of Benitec Biopharma stock can currently be purchased for approximately $12.56.
-
When is Benitec Biopharma's next earnings date?
Unfortunately, Benitec Biopharma's (BNTC) next earnings date is currently unknown.
-
Does Benitec Biopharma pay dividends?
No, Benitec Biopharma does not pay dividends.
-
How much money does Benitec Biopharma make?
Benitec Biopharma has a market capitalization of 252.13M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 188% to 216K US dollars.
-
What is Benitec Biopharma's stock symbol?
Benitec Biopharma Inc. is traded on the NASDAQ under the ticker symbol "BNTC".
-
What is Benitec Biopharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Benitec Biopharma?
Shares of Benitec Biopharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Benitec Biopharma's key executives?
Benitec Biopharma's management team includes the following people:
- Dr. Jerel A. Banks M.D., Ph.D. Chief Executive Officer & Executive Chairman(age: 50, pay: $697,690)
- Ms. Megan Joan Boston BComm, CA, Dip., GAICD Executive Director(age: 53, pay: $401,700)
-
How many employees does Benitec Biopharma have?
As Jul 2024, Benitec Biopharma employs 16 workers, which is 11% less then previous quarter.
-
When Benitec Biopharma went public?
Benitec Biopharma Inc. is publicly traded company for more then 11 years since IPO on 24 Jun 2014.
-
What is Benitec Biopharma's official website?
The official website for Benitec Biopharma is benitec.com.
-
Where are Benitec Biopharma's headquarters?
Benitec Biopharma is headquartered at 3940 Trust Way, Hayward, CA.
-
How can i contact Benitec Biopharma?
Benitec Biopharma's mailing address is 3940 Trust Way, Hayward, CA and company can be reached via phone at +51 07800819.
-
What is Benitec Biopharma stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Benitec Biopharma in the last 12 months, the avarage price target is $20.33. The average price target represents a 61.88% change from the last price of $12.56.
Benitec Biopharma company profile:
Benitec Biopharma Inc.
benitec.comExchange:
NASDAQ
Full time employees:
16
Industry:
Biotechnology
Sector:
Healthcare
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
3940 Trust Way
Hayward, CA 94545
Hayward, CA 94545
CIK: 0001808898
ISIN: US08205P2092
CUSIP: 08205P100
